Skip to main content

Table 1 Clinical characteristics of the 30 patients in the transplantation group

From: Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy

No. Gender GMFCS stage Age (years) LDQ GMFM
1 Female V 1 72 36
2 Female III 3 31.7 176
3 Male III 4 28 189
4 Male III 4 92 185
5 Male V 3 100 50
6 Male IV 2 38 101
7 Male V 4.5 15 23
8 Male IV 4 26.8 115
9 Female V 3 75 42
10 Female IV 13 82 105
11 Female V 1.5 62 38
12 Male V 1 70 31
13 Female V 1 75 20
14 Male IV 2 90 63
15 Male III 4 98 191
16 Female IV 3 30 96
17 Male IV 21 80 82
18 Female III 2 98 120
19 Male IV 5 85 86
20 Female III 8 10 115
21 Female III 4 90 183
22 Female V 5 10 23
23 Female III 12 100 195
24 Male IV 2 98 83
25 Male V 1 15 12
26 Female III 6.5 90 193
27 Female III 4 92 196
28 Female IV 32 73 117
29 Female V 1 54 56
30 Male III 8.5 97 201
  1. The clinical characteristics of the 30 patients in the transplantation group before the cell transplantation treatment are shown. GMFCS: Gross Motor Function Classification System levels; LDQ: language developmental quotient; GMFM: Gross Motor Function Measurement scores.